Background: Up to 20 million persons are infected with the human retroviruses human T-
lymphotropic virus (HTLV)-I and HTLV-II globally. Most data on the seroprevalence of HTLV-I …

Although human T-lymphotropic virus type I (HTLV-I) infection in Europe is thought to be
unusual except amongst people who have immigrated from countries where HTLV-I is …

For 4 years, we determined the mode and risk of mother-to-child transmission of HTLV-I in a
prospective cohort of 34 children born to seropositive mothers in Franceville, Gabon. We …

Background: Prevalence data on human T-lymphotropic virus types 1 and 2 (HTLV-1/2) in
Sweden have not been updated since 1995. The seroprevalence among blood donors at …

The aim of this study was to compare rates of human T-cell lymphotropic virus type I (HTLV-I)
seroprevalence in pregnant women belonging to different ethnic groups in French Guiana …

In this report, the results of seroepidemiologic studies of human T-lymphotropic virus type I
(HTLV-I) and type II (HTLV-II) infections in different population groups in Argentina have …

To assess the prevalence and incidence of human T‐cell lymphotropic virus type I (HTLV‐I),
4,234 pregnant women of different ethnic origins were tested before each delivery between …

Risk factors for male-to-female sexual transmission of human T-lymphotropic virus types I
and II (HTLV-I/II) were investigated among HTLV-seropositive volunteer blood donors and …

Abstract In the United States, blood donors have been routinely screened for human T-cell
lymphotropic virus (HTLV) since 1988. HTLV-I and-II seropositive blood donors have been …

Human T‐lymphotropic virus type 1 and 2 (HTLV‐1 and HTLV‐2) infections in Europe are
limited to intravenous drug users and migrants coming from areas in which they are …